Literature DB >> 19442073

Natriuretic peptide guided heart failure management.

Asim A Mohammed1, James L Januzzi.   

Abstract

BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442073     DOI: 10.2174/157488409788184945

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  3 in total

1.  Brain Natriuretic Peptide as the long-term cause of mortality in patients with cardiovascular disease: a retrospective cohort study.

Authors:  Chunhong Zhang; Dangsheng Huang; Dong Shen; Liwei Zhang; Yumei Wang; Hongyan Sun; Yongjiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

3.  Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction.

Authors:  Vinicio A de Jesus Perez; Francois Haddad; Roham T Zamanian
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.